{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:42Z","timestamp":1787020182943,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373101"],"award-info":[{"award-number":["82373101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Natural Science Foundation of Fujian Province","award":["2023J011239"],"award-info":[{"award-number":["2023J011239"]}]},{"name":"Fujian Cancer Hospital High-level Personnel Project, China","award":["2022YNG-11"],"award-info":[{"award-number":["2022YNG-11"]}]},{"name":"Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies","award":["2021Y2014"],"award-info":[{"award-number":["2021Y2014"]}]},{"name":"Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies","award":["2021Y2014"],"award-info":[{"award-number":["2021Y2014"]}]},{"name":"National Clinical Key Specialty Construction Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13414-z","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:05:34Z","timestamp":1736312734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03\u00a0A)"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuanji","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"3","key":"13414_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"13414_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/doy128","volume":"32","author":"CT Bakhos","year":"2019","unstructured":"Bakhos CT, Salami AC, Kaiser LR, et al. Outcomes of octogenarians with esophageal cancer: an analysis of the National Cancer Database. Dis Esophagus. 2019;32(10):1\u20138.","journal-title":"Dis Esophagus"},{"issue":"2","key":"13414_CR3","first-page":"111","volume":"46","author":"Y Hamamoto","year":"2016","unstructured":"Hamamoto Y, Akutsu Y, Nagashima F, et al. Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group. Jpn J Clin Oncol. 2016;46(2):111\u20135.","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"13414_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.athoracsur.2011.11.035","volume":"93","author":"M Reeh","year":"2012","unstructured":"Reeh M, Nentwich MF, von Loga K, et al. An attempt at validation of the Seventh edition of the classification by the International Union Against Cancer for esophageal carcinoma. Ann Thorac Surg. 2012;93(3):890\u20136.","journal-title":"Ann Thorac Surg"},{"key":"13414_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.radonc.2022.06.010","volume":"174","author":"J Gong","year":"2022","unstructured":"Gong J, Zhang W, Huang W, et al. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: a multicenter study. Radiother Oncol. 2022;174:8\u201315.","journal-title":"Radiother Oncol"},{"issue":"3","key":"13414_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.21037\/atm-20-1460","volume":"9","author":"P Wang","year":"2021","unstructured":"Wang P, Yang M, Wang X, et al. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy. Ann Transl Med. 2021;9(3):233.","journal-title":"Ann Transl Med"},{"key":"13414_CR7","doi-asserted-by":"publisher","first-page":"107327482311850","DOI":"10.1177\/10732748231185025","volume":"30","author":"Z Xu","year":"2023","unstructured":"Xu Z, Ke H, Zheng B, et al. The Prognostic significance of Nomogram-based pretreatment inflammatory indicators in patients with esophageal squamous cell carcinoma receiving intensity-modulated Radiotherapy. Cancer Control. 2023;30:10732748231185025.","journal-title":"Cancer Control"},{"issue":"6","key":"13414_CR8","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.ejso.2020.12.004","volume":"47","author":"CY Shao","year":"2021","unstructured":"Shao CY, Liu XL, Yao S, et al. Development and validation of a new clinical staging system to predict survival for esophageal squamous cell carcinoma patients: application of the nomogram. Eur J Surg Oncol. 2021;47(6):1473\u201380.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"13414_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s12094-016-1603-0","volume":"19","author":"H Yin","year":"2017","unstructured":"Yin H, E M, Zhang H, et al. The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma. Clin Transl Oncol. 2017;19(6):742\u20139.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"13414_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.21873\/invivo.11560","volume":"33","author":"G Suzuki","year":"2019","unstructured":"Suzuki G, Yamazaki H, Aibe N, et al. Definitive Radiotherapy for older patients aged >\/=75 years with localized esophageal Cancer. Vivo. 2019;33(3):925\u201332.","journal-title":"Vivo"},{"issue":"1","key":"13414_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10388-021-00876-4","volume":"19","author":"N Takahashi","year":"2022","unstructured":"Takahashi N, Umezawa R, Kishida K, et al. Clinical outcomes and prognostic factors for esophageal cancer in patients aged 80 years or older who were treated with definitive radiotherapy and chemoradiotherapy. Esophagus. 2022;19(1):129\u201336.","journal-title":"Esophagus"},{"key":"13414_CR12","doi-asserted-by":"publisher","first-page":"1008326","DOI":"10.3389\/fonc.2022.1008326","volume":"12","author":"S Qie","year":"2022","unstructured":"Qie S, Shi H, Wang F, et al. Construction of survival prediction model for elderly esophageal cancer. Front Oncol. 2022;12:1008326.","journal-title":"Front Oncol"},{"issue":"10","key":"13414_CR13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1001\/jamaoncol.2021.2705","volume":"7","author":"Y Ji","year":"2021","unstructured":"Ji Y, Du X, Zhu W, et al. Efficacy of concurrent Chemoradiotherapy with S-1 vs Radiotherapy alone for older patients with esophageal Cancer: a Multicenter Randomized Phase 3 clinical trial. JAMA Oncol. 2021;7(10):1459\u201366.","journal-title":"JAMA Oncol"},{"issue":"5","key":"13414_CR14","doi-asserted-by":"publisher","first-page":"e2312625","DOI":"10.1001\/jamanetworkopen.2023.12625","volume":"6","author":"X Wang","year":"2023","unstructured":"Wang X, Han W, Zhang W, et al. Effectiveness of S-1-Based chemoradiotherapy in patients 70 years and older with esophageal squamous cell carcinoma: a Randomized Clinical Trial. JAMA Netw Open. 2023;6(5):e2312625.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"13414_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12885-019-6461-z","volume":"20","author":"M Chen","year":"2020","unstructured":"Chen M, Liu X, Han C, et al. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A). BMC Cancer. 2020;20(1):36.","journal-title":"BMC Cancer"},{"issue":"10","key":"13414_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jcma.2017.06.014","volume":"80","author":"MQ Chen","year":"2017","unstructured":"Chen MQ, Lin QL, Chen YG, et al. Neoadjuvant chemotherapy may not benefit esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. J Chin Med Assoc. 2017;80(10):636\u201343.","journal-title":"J Chin Med Assoc"},{"issue":"11","key":"13414_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-150-11-200906020-00007","volume":"150","author":"NR Cook","year":"2009","unstructured":"Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150(11):795\u2013802.","journal-title":"Ann Intern Med"},{"issue":"1","key":"13414_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40169-019-0252-7","volume":"9","author":"J Li","year":"2020","unstructured":"Li J, Lai C, Peng S, et al. The prognostic value of integration of pretreatment serum amyloid A (SAA)-EBV DNA (S-D) grade in patients with nasopharyngeal carcinoma. Clin Transl Med. 2020;9(1):2.","journal-title":"Clin Transl Med"},{"issue":"5","key":"13414_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(16)00010-3","volume":"17","author":"D Callegaro","year":"2016","unstructured":"Callegaro D, Miceli R, Bonvalot S, et al. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncol. 2016;17(5):671\u201380.","journal-title":"Lancet Oncol"},{"issue":"1","key":"13414_CR20","first-page":"14","volume":"38","author":"W Yao","year":"2018","unstructured":"Yao W, Meng Y, Lu M, et al. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis. Cancer Commun (Lond). 2018;38(1):14.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"13414_CR21","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1245\/s10434-019-07393-w","volume":"26","author":"W Deng","year":"2019","unstructured":"Deng W, Zhang W, Yang J, et al. Nomogram to predict overall survival for thoracic esophageal squamous cell Carcinoma patients after Radical Esophagectomy. Ann Surg Oncol. 2019;26(9):2890\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"13414_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301\u201312.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"13414_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/CM9.0000000000001837","volume":"135","author":"X Yang","year":"2022","unstructured":"Yang X, Yang Y, Weng X, et al. Nomogram for predicting disease-specific survival in osteosarcoma. Chin Med J (Engl). 2022;135(9):1126\u20138.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"13414_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.21147\/j.issn.1000-9604.2020.01.12","volume":"32","author":"HK Hwang","year":"2020","unstructured":"Hwang HK, Wada K, Kim HY, et al. A nomogram to preoperatively predict 1-year disease-specific survival in resected pancreatic cancer following neoadjuvant chemoradiation therapy. Chin J Cancer Res. 2020;32(1):105\u201314.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"13414_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jchf.2019.06.013","volume":"8","author":"S Angraal","year":"2020","unstructured":"Angraal S, Mortazavi BJ, Gupta A, et al. Machine learning prediction of mortality and hospitalization in heart failure with preserved ejection fraction. JACC Heart Fail. 2020;8(1):12\u201321.","journal-title":"JACC Heart Fail"},{"issue":"14","key":"13414_CR26","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/sim.5647","volume":"32","author":"H Uno","year":"2013","unstructured":"Uno H, Tian L, Cai T, et al. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013;32(14):2430\u201342.","journal-title":"Stat Med"},{"issue":"1","key":"13414_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12874-022-01801-8","volume":"22","author":"MAE Binuya","year":"2022","unstructured":"Binuya MAE, Engelhardt EG, Schats W, et al. Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review. BMC Med Res Methodol. 2022;22(1):316.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"13414_CR28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1186\/s12885-021-08838-w","volume":"21","author":"Y Chen","year":"2021","unstructured":"Chen Y, Huang Q, Chen J, et al. Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer. BMC Cancer. 2021;21(1):1130.","journal-title":"BMC Cancer"},{"issue":"6","key":"13414_CR29","first-page":"760","volume":"21","author":"X Liu","year":"2021","unstructured":"Liu X, Guo W, Shi X, et al. Construction and verification of prognostic nomogram for early-onset esophageal cancer. Bosn J Basic Med Sci. 2021;21(6):760\u201372.","journal-title":"Bosn J Basic Med Sci"},{"issue":"10","key":"13414_CR30","doi-asserted-by":"publisher","first-page":"e2019440","DOI":"10.1001\/jamanetworkopen.2020.19440","volume":"3","author":"H Luo","year":"2020","unstructured":"Luo H, Jiang W, Ma L, et al. Icotinib with Concurrent Radiotherapy vs Radiotherapy alone in older adults with unresectable esophageal squamous cell carcinoma: a phase II randomized clinical trial. JAMA Netw Open. 2020;3(10):e2019440.","journal-title":"JAMA Netw Open"},{"issue":"35","key":"13414_CR31","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1200\/JCO.20.01888","volume":"38","author":"T Kojima","year":"2020","unstructured":"Kojima T, Shah MA, Muro K, et al. Randomized Phase III KEYNOTE-181 study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer. J Clin Oncol. 2020;38(35):4138\u201348.","journal-title":"J Clin Oncol"},{"issue":"4","key":"13414_CR32","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u2013180.","journal-title":"Lancet Oncol"},{"issue":"2","key":"13414_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10388-020-00795-w","volume":"18","author":"K Kouzu","year":"2021","unstructured":"Kouzu K, Tsujimoto H, Sugasawa H, et al. Modified geriatric nutrition risk index as a prognostic predictor of esophageal cancer. Esophagus. 2021;18(2):278\u201387.","journal-title":"Esophagus"},{"issue":"3","key":"13414_CR34","first-page":"1815","volume":"38","author":"D Bernardi","year":"2018","unstructured":"Bernardi D, Asti E, Aiolfi A, et al. Outcome of Trimodal Therapy in Elderly patients with esophageal Cancer: Prognostic Value of the Charlson Comorbidity Index. Anticancer Res. 2018;38(3):1815\u201320.","journal-title":"Anticancer Res"},{"issue":"1","key":"13414_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12876-016-0549-6","volume":"16","author":"N Wu","year":"2016","unstructured":"Wu N, Zhu Y, Kadel D, et al. The prognostic influence of body mass index, resting energy expenditure and fasting blood glucose on postoperative patients with esophageal cancer. BMC Gastroenterol. 2016;16(1):142.","journal-title":"BMC Gastroenterol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13414-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13414-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13414-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:04:19Z","timestamp":1736316259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13414-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13414"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13414-z","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We formally confirm that all experiments were strictly conducted in accordance with the relevant guiding principles and regulations. This restrospective study was approved by the Ethics Committee of Fujian Cancer Hospital (Approval No. SQ2019-037-01) and the National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital (Approval No. NCC2016-06). All patients provided written informed consent prior to treatment, and all information was anonymized prior to analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}